Related Experiment Video
Updated: Jun 20, 2026
08:49
Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
Published on: January 12, 2012
Dopamine D(2)-class receptor supersensitivity as reflected in Ca2+ current modulation in neostriatal neurons
G A Prieto1, A Perez-Burgos, T Fiordelisio
1Instituto de Fisiología Celular-Neurociencias, Universidad Nacional Autónoma de México.
Neuroscience
|August 25, 2009
Summary
Parkinson's disease causes dopamine depletion, leading to D2 receptor supersensitivity. This study identifies an electrophysiological correlate of this supersensitivity in rat striata, revealing altered calcium channel function.
Area of Science:
- Neuroscience
- Neuropharmacology
- Electrophysiology
Background:
- Parkinson's disease is characterized by dopaminergic neuron loss and dopamine depletion in the neostriatum.
- Striatal dopamine depletion results in D2 receptor class supersensitivity, a phenomenon documented through various methods but lacking clear electrophysiological evidence.
Purpose of the Study:
- To identify an electrophysiological correlate of D2 receptor class supersensitivity in dopamine-depleted striata.
- To investigate the functional changes in calcium (Ca2+) current modulation by D2 receptor class activation post-lesion.
Main Methods:
- Unilateral 6-hydroxydopamine (6-OHDA) lesions in the rat substantia nigra compacta (SNc) to induce dopamine depletion.
- Electrophysiological recordings in DA-depleted and control rat striata.
- Analysis of concentration-response relationships for Ca2+ current modulation by D2 receptor class agonists.
Main Results:
- Dopamine-depleted striata exhibited altered sensitivity to D2 receptor class activation.
- Concentration-response curves shifted leftward and showed increased maximal response in DA-depleted striata compared to controls.
- The data best fit a three-site model in depleted striata versus a two-site model in controls.
Conclusions:
- The study provides an electrophysiological correlate for D2 receptor class supersensitivity in Parkinson's disease models.
- Altered Ca2+ current modulation impacts spiny neuron excitability and GABA release, potentially explaining functional changes in the striatal circuitry.
- These findings contribute to understanding the neurophysiological consequences of dopaminergic denervation.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...